Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 12:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 1,017 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Systemic Infection Clear all

Conditions: Candidiasis
Interventions: Fluconazole Loading Dose, Fluconazole Loading Dose & High Dose; Drug
Lead sponsor: Daniel Benjamin; Other
Eligibility: 48 Hours to 2 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Septic Shock, Sepsis, Shock
Interventions: Not listed
Lead sponsor: Albany Medical College; Other
Eligibility: Not listed
Enrollment: 50 participants
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Albany, New York

Conditions: Infective Endocarditis
Interventions: daptomycin, daptomycin and gentamicin; Drug
Lead sponsor: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA); Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 4
States / cities: Denver, Colorado • Detroit, Michigan • Philadelphia, Pennsylvania

Conditions: Sepsis, Respiratory Distress Syndrome, Respiratory Distress Syndrome, Adult
Interventions: vasoactive intestinal peptide; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1998
U.S. locations: 2
States / cities: Northport, New York • Stony Brook, New York

Conditions: Sepsis
Interventions: Imipenem, Cilastatin and Relebactam; Drug
Lead sponsor: Joseph L. Kuti, PharmD; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: COVID-19, Endothelial Function
Interventions: Vascular occlusion test; Device
Lead sponsor: Corporacion Parc Tauli; Other
Eligibility: 18 Years and older
Enrollment: 612 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Sepsis
Interventions: Acupuncture, Sham Acupuncture; Procedure · Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Irvine, California

Conditions: Healthcare-Associated Pneumonia, Sepsis
Interventions: antimicrobial initiation; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Sepsis, Septic Shock, Sepsis, Severe, Volume Overload
Interventions: VExUS score; Diagnostic Test
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Bacteremia, Infective Endocarditis
Interventions: Oral Hygiene instruction, Dental Cleaning; Behavioral · Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 6
States / cities: Boston, Massachusetts • Ann Arbor, Michigan • Newark, New Jersey + 3 more

Conditions: Catheter-related Bloodstream Infection Due to Central Venous Catheter
Interventions: Disinfecting Cap; Device
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 4
States / cities: Evanston, Illinois • Glenview, Illinois • Highland Park, Illinois + 1 more

Conditions: Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Pain, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: methadone hydrochloride, morphine sulfate, oxycodone hydrochloride; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Spartanburg, South Carolina • Houston, Texas

Conditions: Sepsis, Venous Thromboembolism, Disseminated Intravascular Coagulation
Interventions: Diagnosis of both VTE and sepsis; Other
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Whippany, New Jersey

Conditions: Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: St. John's wort; Dietary Supplement
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 1
States / cities: New York, New York

Conditions: Bacteremia
Interventions: Telavancin, Vancomycin, Daptomycin, Synthetic penicillin, Cefazolin; Drug
Lead sponsor: Cumberland Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Severe Sepsis, Septic Shock
Interventions: BMS-936559, Placebo; Biological · Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 13
States / cities: Sacramento, California • Denver, Colorado • Gainesville, Florida + 10 more

Conditions: Cardiovascular Disease, Periodontal Disease
Interventions: Early Periodontal Treatment, Usual Dental Hygiene; Procedure
Lead sponsor: Boston University; Other
Eligibility: 20 Years and older
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infections
Interventions: TriGrid™ Delivery System, conventional intramuscular injection; Device
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Hyperglycemia, Sepsis
Interventions: Dopamine; Drug
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years to 35 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Systemic Autoimmune Diseases
Interventions: Not listed
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 15 Years and older
Enrollment: 293 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sepsis, Infections, Tachycardia, Fever
Interventions: TriVerity Test; Diagnostic Test
Lead sponsor: Inflammatix; Industry
Eligibility: 18 Years and older
Enrollment: 320 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Peoria, Illinois • Baltimore, Maryland

Conditions: BK Virus (BKV) Viremia
Interventions: Not listed
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 6
States / cities: Birmingham, Alabama • San Francisco, California • Denver, Colorado + 3 more

Conditions: Surgical Wound Infection, Cystitis, Bacteremia, Pneumonia, Enterocolitis, Pseudomembranous
Interventions: Synbiotic 2000; Drug
Lead sponsor: Beth Israel Medical Center; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: New York, New York

Conditions: Sepsis, Septic Shock
Interventions: Not listed
Lead sponsor: Bluejay Diagnostics, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 7
States / cities: Boston, Massachusetts • St Louis, Missouri • Brooklyn, New York + 4 more

Search by objective public record fields.

Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers

Delphi Septic Shock: Sub-phenotypes Using Point-of-Care Ultrasound in Patients With Septic Shock

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

Imipenem/Cilastatin/Relebactam PK in ECMO

Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients

An Acupuncture Study for People At High Risk for Sepsis

Trial of Antimicrobial Restraint in Presumed Pneumonia

De-resuscitation Informed by Ultrasound for Patients With Sepsis

Reducing Risk for Infective Endocarditis

Evaluating Central Line Hub Contamination Using a Novel Capping Device

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis

Impact of Gum Infection on Heart Disease

Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers

Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects

Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases

TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections

BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study

Multicenter Symphony IL-6 Monitoring Sepsis ICU Study